No Data
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy
Ginkgo Bioworks, Carnegie Mellon University Secure $9.4 Mln To Build Devices For Disease Treatment
Express News | Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under Arpa-H's React Program
Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program
Ginkgo Bioworks Falls -8.3%
Ferment Launches $20M Studio Fund to Accelerate Biotech Solutions Across Vital Industries
QMengColdJoke : still a fraud after 40 to 1 reverse split.
TechTrek Invest OP QMengColdJoke : That's a very emotional response. Where is the evidence? Have you notified the SEC of your findings?
What's the fraud?
Share price falling isn't fraudulent.
COVID profits fell considerably - again losing revenue streams.is not fraudulent.
Core buisiness is growing.
Good AI development.
Reducing cost.
Ginkgo has good long term.potential.